Theravance Biopharma Files Q1 2025 10-Q
Ticker: TBPH · Form: 10-Q · Filed: May 12, 2025 · CIK: 1583107
| Field | Detail |
|---|---|
| Company | Theravance Biopharma, Inc. (TBPH) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
TBPH Q1 2025 10-Q filed. Financials updated.
AI Summary
Theravance Biopharma, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Key financial figures include retained earnings and additional paid-in capital as of March 31, 2025, and comparative periods.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Theravance Biopharma, Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 50001000 — Other Assets Noncurrent (Reported value for noncurrent other assets.)
- 49471000 — Other Assets Noncurrent (Previous Period) (Comparative value for noncurrent other assets.)
Key Players & Entities
- Theravance Biopharma, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 20250331 (date) — Conformed period of report
- 0001583107 (company) — Central Index Key for Theravance Biopharma, Inc.
FAQ
What is the total amount of retained earnings as of March 31, 2025?
The filing indicates retained earnings as of March 31, 2025, but the specific dollar amount is not directly provided in the excerpt.
What was the company's financial position at the end of the previous fiscal year (December 31, 2024)?
The filing provides figures for retained earnings and additional paid-in capital as of December 31, 2024.
What is the significance of the 'MeasurementInputDiscountRateMember'?
This likely relates to valuation inputs used in financial reporting, such as for leases or other financial instruments, but specific details are not in this excerpt.
What period does the 'tbph:SouthSanFranciscoMember' tag refer to?
This tag is associated with financial data for the periods January 1, 2025, to December 31, 2026, January 1, 2025, to March 31, 2025, and January 1, 2024, to March 31, 2024, suggesting it relates to operations or reporting segments in that location.
What is the filing date of this 10-Q report?
The filing date is May 12, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Theravance Biopharma, Inc. (TBPH).